Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 14, Issue 4, 1999, Pages 903-909

  Pauli Magnus, Christiane ^a   Hofmann, Ute ^a   Mikus, Gent ^a   Kuhlmann, Ulrich ^b   Mettang, Thomas ^b  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Morphine; Morphine glucuronides; Peritoneal dialysis; Pharmacokinetics; Renal failure

Indexed keywords

DRUG METABOLITE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; MASS SPECTROMETRY; PAIN; PRIORITY JOURNAL;

EID: 0032890987     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.4.903     Document Type: Article

References (18)

1. Milne RW, Nation RL, Somogyi AA. The disposition of morphine and its 3-and 6-glucuronide metabolites in human and animals, and the importance of the metabolites to the pharmacological effects of morphine Drug Metab Rev 1996; 28: 345-472
2. Osborne RJ, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after different routes of morphine administration. Demonstration of the importance of the active metaolite morphine-6-glucuronide. Clin Pharmacol Ther 1990; 47: 12-19
3. Chauvin M, Sandouk P, Scherrmann JM et al. Morphine pharmocokinetics in renal failure. Anesthesiology 1987; 66: 327-331
4. Sawe J, Odar-Cederlof I. Kinetics of morphine in patients with renal failure. Eur J Clin Pharmacol 1987; 32: 377-821
5. Osborne RJ, Simon PJ, Slevin ML. Morphine intoxication in renal failure. The role of morphine-6-glucuronide. Br Med J 1986; 292; 1548-1549
6. Ashby M, Fleming B, Wood M, Somogyi A. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients. J Pain Sympt Manag 1997; 14: 157-167
7. Shimomura K, Kamata O, Ueki S et al. Analgesic effect of morphine glucuronides. Tohoku J Exp Med 1971; 105: 45-52
8. Paul D, Standifer KM, Inturrissi CE et al. Pharmacological characterization of morphine-6-beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther 1989; 251: 477-483
9. Hofmann U, Fromm MF, Johnson S et al. Simultaneous determination of dihydrocodeine and dihyhydromorphine in serum by gas chromatography-tandem mass spectrometry. J Chromatogr B 1995; 663: 59-65
10. Tyrefors N, Hyllbrant B, Ekman L et al. Determination of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human serum by solid-phase extraction and liquid chromatography-mass spectromety with electrospray ionisation. J Chromatogr A 1996; 729: 279-285
11. Faura CC, Collins SL, Moore RA, McQuay HJ. Systematic review of factors affecting ratios of morphine and its major metabolites. Pain 1998; 74: 43-53
12. Paul D, Standifer KM, Inturrisi CE et al. Pharmacological characterization of morphine-6-beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther 1989; 25: 477-483
13. Hanna MH, Peat SJ, Woodham M et al. Efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine. Br J Anaesth 1990; 64: 547-550
14. Huwyler J, Drewe J, Klusemann et al. Evidence for P-glycoprotein modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br J Parmacol 1996; 118: 1879-1885
15. Mickisch GH, Kossig J, Tschada R et al. Circumvention of multidrug resistance mediated by P-170 glycoprotein using calcium anatgonists in primary human renal cell carcinoma. Urol Int 1991; 47: 118-125
16. Schinkel AH, Wagenaar E, van Deetmer L et al. Absence of the mdrla P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporine A. J Clin Invest 1995; 96: 1698-1705
17. Varga A, Nugel H, Bachr R et al. Reversal of multidrug resistance by amitriptyline in vitro. Anticancer Res 1996; 16: 209-211
18. Lötsch J, Kobal G, Stockmann A et al. Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology 1997; 87: 1348-1358